A PHASE II TRIAL OF GEMCITABINE, IFOSFAMIDE, DEXAMATHASONE, AND OXALIPLATIN (GIDOX) FOR PATIENTS WITH REFRACTORY OR RELAPSED NON-HODGKIN'S LYMPHOMA

被引：0
|
作者：
Park, B. B. [1 ]
Kim, W. S. [2 ]
Eom, H. S. [3 ]
Kim, J. S. [4 ]
Oh, S. J. [5 ]
Hwang, I. G. [6 ]
Suh, C. [7 ]
机构：
[1] Hanyang Univ, Coll Med, Seoul 133791, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[3] Natl Canc Ctr, Res Inst & Hosp, Goyang, South Korea
[4] Yonsei Univ, Coll Med, Seoul, South Korea
[5] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Seoul, South Korea
[6] Chung Ang Univ, Sch Med, Seoul 156756, South Korea
[7] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1701
引用
收藏
页码：652 / 652
页数：1
相关论文
共 50 条
  • [41] A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma
    A Younes
    J M Vose
    A D Zelenetz
    M R Smith
    H A Burris
    S M Ansell
    J Klein
    W Halpern
    R Miceli
    E Kumm
    N L Fox
    M S Czuczman
    British Journal of Cancer, 2010, 103 : 1783 - 1787
  • [42] Options: Relapsed and refractory non-Hodgkin's lymphoma
    Friedberg, Jonathan W.
    CANCER INVESTIGATION, 2007, 25 : 36 - 37
  • [43] Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma
    Dang, Nam H.
    Pro, Barbara
    Hagemeister, Fredrick B.
    Samaniego, Felipe
    Jones, Dan
    Samuels, Barry I.
    Rodriguez, Maria A.
    McLaughlin, Peter
    Tong, Ann T.
    Turturro, Francesco
    Walker, Pamela L.
    Fayad, Luis
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (03) : 439 - 447
  • [44] Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma
    Hertzberg, M. S.
    Crombie, C.
    Benson, W.
    Taper, J.
    Gottlieb, D.
    Bradstock, K. F.
    ANNALS OF ONCOLOGY, 2006, 17 : 25 - 30
  • [45] Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia:: a phase II multicenter trial
    Wiseman, GA
    Gordon, LI
    Multani, PS
    Witzig, TE
    Spies, S
    Bartlett, NL
    Schilder, RJ
    Murray, JL
    Saleh, M
    Allen, RS
    Grillo-López, AJ
    White, CA
    BLOOD, 2002, 99 (12) : 4336 - 4342
  • [46] Ifosfamide, gemcitabine, and vinorelbine: a now induction regimen for refractory and relapsed Hodgkin's lymphoma
    Santoro, Armando
    Magagnoli, Massimo
    Spina, Michele
    Pinotti, Graziella
    Siracusano, Licia
    Michieli, Mariagrazia
    Nozza, Andrea
    Sarina, Barbara
    Morenghi, Emanuela
    Castagna, Luca
    Tirelli, Umberto
    Balzarotti, Monica
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (01): : 35 - 41
  • [47] COMPLETE RESPONSE TO IGEV (IFOSFAMIDE, GEMCITABINE AND VINORELBINE) AND OUTCOME IN RELAPSED/REFRACTORY HODGKIN'S LYMPHOMA PATIENTS
    Anastasia, A.
    Mazza, R.
    Giordano, L.
    Balzarotti, M.
    Magagnoli, M.
    Castagna, L.
    Spina, M.
    Tirelli, U.
    Santoro, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 37 - 37
  • [48] An update on gemcitabine, rituximab, and oxaliplatin in combination for relapsed/refractory non-Hodgkin lymphomas.
    Crescentini, Robert M.
    Sweet, Kendra Lynn
    Liu, Jijun
    Liboy, Idalia
    Dalia, Samir
    Chavez, Julio C.
    Bello, Celeste M.
    Sokol, Lubomir
    Sotomayor, Eduardo M.
    Cabanillas, Fernando
    Cultrera, Jennifer L.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [49] Oxaliplatin (LOHP): A new platinum analog active on refractory/relapsed non-Hodgkin's lymphoma
    Germann, N
    Soulie, P
    Brienza, S
    Rotarsky, M
    Emile, JF
    Di Palma, M
    Musset, M
    Reynes, M
    Cvitkovic, E
    Misset, JL
    ANNALS OF ONCOLOGY, 1998, 9 : 110 - 110
  • [50] Liposomal vincristine: A phase II trial in relapsed or refractory non-Hodgkin's lymphomas (NHL).
    Sarris, AH
    Romaguera, SJ
    Hagemeister, F
    Rodriguez, MA
    McLaughlin, P
    Dang, N
    Tsimberidou, AM
    Medeiros, LJ
    Samuels, B
    Oholendt, M
    Pate, O
    Burge, C
    Cabanillas, F
    BLOOD, 1999, 94 (10) : 94A - 94A
12345